Author:
Kelbsch Carina,Richter Paul
Publisher
Springer Berlin Heidelberg
Reference13 articles.
1. Butler NJ, Furtado JM, Winthrop KL, Smith JR. Ocular toxoplasmosis II: clinical features, pathology and management. Clin Exp Ophthalmol. 2013;41(1):95–108.
2. DOG-Leitlinie Nr. 14 Uveitis anterior, Berufsverband der Augenärzte Deutschlands e.V. und Deutsche Ophthalmologische Gesellschaft e.V. 2010. Zugriffsdatum 16.08.2021. https://www.dog.org/wp-content/uploads/2009/09/LL-Uveitis-anterior-2011-11-30-Endversion.pdf
3. Eckert GU, Melamed J, Menegaz B. Optic nerve changes in ocular toxoplasmosis. Eye (Lond). 2007;21(6):746–51.
4. Eggenberger ER. Infectious optic neuropathies. Continuum (Minneap Minn). 2019;25(5):1422–37.
5. Gilbert RE, Dunn DT, Lightman S, Murray PI, Pavesio CE, Gormley PD, Masters J, Parker SP, Stanford MR. Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect. 1999;123(2):283–9.